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a b s t r a c t
INTRODUCTION: Catamenial pneumothorax (CP) is a spontaneous recurrent pneumothorax occurring in
women in reproductive age. The etiology of CP has been associated with thoracic endometriosis and is
its most common presentation.
PRESENTATION OF CASE: A case of right catamenial pneumothorax in a 38 year old woman is presented in
which three episodes of CP occurred within 72h of menses in a 6 month period. The patient underwent
videothoracoscopy that revealed a solitary localization of diaphragmatic endometriosis. After surgical
pleurodesis andbasedonﬁnalpathologyof resected lesion,hormonal treatmentwas started. Theoutcome
was uneventful and the patients is symptom-free at 6 months.
DISCUSSION: Catamenial pneumothorax (CP) is a rare clinical entity characterized by lung collapse during
menstruation, believed to be secondary to pleural endometriosis. Nearly all catamenial pneumothorax
occur on the right side aspleural lesions are almost exclusively right-sided.Diagnostic imaging is basedon
high resolution computed tomography (HRCT) and, preferably,magnetic resonance imaging (MRI) since it
is able to detect the bloodproducts in the endometrial deposits. However the lack ofmacroscopic ﬁndings
at surgery makes this condition still under-diagnosed. Based on the solitary diaphragmatic localization
of endometriosis in our case we preferred to limit surgery to videothoracoscopic pleurodesis and start
hormonal treatment with successful outcome.
CONCLUSION: Catamenial pneumothorax is the most common presentation of thoracic endometriosis
syndrome and should always be suspected in women in childbearing age. Treatment option are still
debated but best results are achieved by videothoracoscopic pleurodesis combined with hormonal ther-
apy.
© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Catamenial pneumothorax (CP) is a spontaneous recurrent
pneumothorax occurring in women in reproductive age. The etiol-
ogy of CP has been associated with thoracic endometriosis namely
the presence of endometrial-like tissue in the thoracic cavity [1,2].
Thoracic endometriosis is considered a rare condition, usually
underdiagnosed,which consists of 4different clinical entities: cata-
menial pneumothorax, catamenial hemothorax, hemoptysis and
pulmonary nodules [3,4]. About 60% of pulmonary endometriosis
cases are associatedwith pelvic endometriosis [1,5]. Etiopathogen-
esis of thoracic endometriosis is not clear and the most accredited
theory explains the retrograde implantation of endometrial tissue
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by lymphatic and haematogenous dissemination or presence of
diaphragmatic defects [2]. CP is the most common presentation of
thoracic endometriosis syndrome (TES), with a reported incidence
of 2.8–5.6% [2,6]. CP accounts for >30% of all cases of spontaneous
pneumothorax in youngwomenwith a peak incidence between 30
and 35 years [3,4]. CP typically occurs within 24h before and 72h
after the onset of menses and appears almost exclusively in the
right hemithorax [1].
A combined surgical and hormonal treatment [7] is considered
the best management of CP, as postoperative recurrences are com-
mon and hormonal therapy is useful to prevent them [3,6]. We
present a case of recurrent catamenial pneumothorax due to a
single diaphragmatic endometriosis localization which was suc-
cessfully treated with combined surgical and hormonal therapy.
http://dx.doi.org/10.1016/j.ijscr.2015.05.012
2210-2612/© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. Typical purple–red spot on the right posterior diaphragmatic surface (black
arrow) strongly suggestive of endometriosis localization.
2. Case presentation
A 38-year-old otherwise healthy woman had 3 episodes of
recurrent spontaneous right pneumothorax in the past sixmonths.
The 1st episode resolved spontaneously after 10 days. Twomonths
later the patient was hospitalized because of shortness of breath
and chest pain and a 2nd right pneumothoraxwas diagnosedwhich
also resolved spontaneously after 3 weeks. After two more months
a 3rd episode happened always on the right side, and a better
analyzed clinical history revealed that all episodes were related
to peri-menstruation period with the 3rd one occurring during
menses. All episodes of pneumothorax were evaluated by chest
roentgenogram and computed tomography (CT) which did not
show any blebs or bullae. Although the patient did not have any
history of pelvic or abdominal pain, her serumCa125 levelwas nor-
mal (22g/mL), and further evaluation by pelvic ultrasonography
and magnetic resonance imaging (MRI) excluded the presence of
pelvic endometriosis, the hypothesis of catamenial pneumothorax
was taken into account.
The patient underwent a videothoracoscopic exploration of
the right pleural cavity under general anesthesia and single-lung
ventilation by a ﬁrst posterolateral access. The examination of
pleural cavity showed a single typical purple–red spot on the
right posterior pleural diaphragmatic surface strongly suggestive
of endometriosis (Fig. 1). No other anomalies nor holes on the over-
all diaphragmatic extension were detected. A second incision was
made to perform pleurodesis by mechanical abrasion and surgical
resection of diaphragmatic lesion. After control of hemostasis a 24
Ch drain was placed in pleural space and full lung re-expansion
achieved. The chest tube was left in place until postoperative day
3 when the patient was discharged. Final pathology conﬁrmed an
endometriosis-related catamenial pneumothorax (ER–CP) accord-
ing the most updated classiﬁcation by Legras et al. [8] (Fig. 2).
Soon after surgery the patient started a medical treatment
with 17-etinil testosterone 800mg daily which was shifted to
dienogest 2mg daily due to marked untolerable hypoestrogenic
side effects following gynecologist’s outpatient follow up. At 6
months from surgery no recurrence has been observed.
3. Discussion
Catamenial pneumothorax (CP) is a rare clinical entity char-
acterized by lung collapse during menstruation (catamenial is a
derivation of the Greek term katam
′
e¯nios that refers to monthly),
believed to be secondary to endometriosis within the pleural cav-
ity and causing 1/3 of spontaneous pneumothorax in women of
child-bearing age [1,8]. Although the progressive improvement in
Fig. 2. Histology of resected specimen: diaphragm muscle tissue with endometrio-
sis spot in which endometrial glands and stromal cells without atypia can be
recognized (black arrow, hematoxylin-eosine 10×).
imaging techniques andminimally invasive procedures, the lack of
macroscopic ﬁndings at surgery makes this condition still under-
diagnosed with a reported incidence of 3–5% [1,3,9]. The disease
more frequently occurs in premenopausalwomen aged 30–50who
have a history of infertility, severe endometriosis and recurrent
spontaneous pneumothorax within 72h of the onset of menses
[6,9].
Endometriosis predominantly affects 5–10% of women in
reproductive age andmay be extragenital. CP is considered amani-
festation of thoracic endometriosis, rarely present in endometriosis
[10]. Pleural endometriosis presents as catamenial pneumotho-
rax, catamenial hemothorax, catamenial pneumomediastinum and
chest pain. The pulmonary formpresents as catamenial hemoptysis
and pulmonary nodules. Both forms are part of the so called tho-
racic endometriosis syndrome(TES) [11]. Three theoriesexplain the
etiology of CP. The metastatic theory assumes the transdiaphrag-
matic passage of endometrial tissue by lympho-hematogenous
dissemination or congenital fenestration. The anatomical theory
calls for dissolution of cervical mucus plug during the menses with
migration of cells through vagina, uterus, fallopian tubes to peri-
toneum and air reaching the chest by diaphragmatic congenital
fenestrations. In the hormonal theory prostaglandin F2 mediated
pulmonary vasospasm during ovulation leads to ischemic injury
and alveolar rupture [4,6]. Congenital diaphragmatic defects are
more common on the right side and this can explain the higher
prevalence of right-sided CP. The prevalence of diaphragmatic fen-
estrations varies from 23% to 88%, and diaphragmatic fenestrations
can be associated with endometrial implants [12]. The diaphrag-
matic defect(s) can be single or multiple, usually located at the
central tendon, and are described as perforations, holes, fenes-
trations, pores, porosities, and stomata. There can be “invisible”
holes proven only by diagnostic pneumoperitoneum, tiny holes
(1–3mm), or larger defects (>10mm) [13]. As seen in this case
and in most reports, nearly in all cases catamenial pneumothorax
occurs on the right side as pleural lesions are almost exclusively
right-sided. This predilection is probably due to the more exten-
sive diaphragmatic lymphatic drainage on the right side and the
clockwise peritoneal circulation that sweeps endometrial implants
to the right diaphragm [11,12]. Diagnostic imaging is based on high
resolution computed tomography (HRCT) to detect endometrial
deposits in the lung and pleura and pelvic ultrasound due to coex-
istence of pulmonary and pelvic endometriosis in 50–80% of cases
[14,15]. Both thoracic and pelvic MRI are considered superior to CT
due to the blood products in the endometrial deposits. Typical MRI
pattern showsa centrally or peripherally located low-intensity area
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in the hyperintense cyst on T2weighted images (shading). Thoracic
MRI lesions are hyperintense on T2-weighted spin-echo, increase
in size at the time of menstruation and show pronounced uptake
contrast agent as comparedwith the intermenstrual period [11,16].
CA125 (Cancer Antigen 125) is a tumor marker that is widely used
to monitor ovarian cancer because it is overexpressed in ovarian
cancer cells and secreted into the blood. Serum CA125 is used in
monitoring treatment and detecting recurrence in ovarian cancer.
CA-125 levels may be elevated in a variety of benign ovarian con-
ditions, such as pelvic inﬂammatory disease, endometriosis, and
benign neoplasms. Endometriosis has also been associated with
increased levels of CA-125, and although it is not considered a spe-
ciﬁcmarker, it canassist in earlydiagnosis of endometriosis-related
pneumothorax [13,17]. Bagan et al. suggest CA-125 measurement
be included in females of reproductive age presentingwith primary
spontaneous pneumothorax without gynaecological orientation
and without clinical signs of malignant and nonmalignant condi-
tions that injuremesothelial cells. Theyconclude that thisbiological
marker may favor indication of videothoracoscopy and hormonal
therapy at an early stage in the prevention of catamenial pneu-
mothorax recurrences, and should be evaluated prospectively in a
larger-scale study [18].
Moreover in a study conducted by Pickhardt and Hanson [19]
to determine the prevalence, work-up, and outcomes of indeter-
minate adnexal masses in asymptomatic women, the only case of
elevated CA-125 was associated with endometriosis. However, Ca-
125 levels only reﬂect the amount of endometrial tissue, and it is
currently believed that theusefulness of suchmeasurements is low.
As a matter of fact in our case Ca-125 levels were in normal range.
Management of pulmonary endometriosis can be either med-
ical or surgical. Medical treatment is based on the use of drugs
that can induce endometrial hypotrophy. First choice treatment is
represented by continuative progestinic administration. Medical
treatment using 17-etinil testosterone a derivative of the syn-
thetic steroid ethisterone has been advised since it suppresses the
production of gonadotropins, thus leading to a condition of pseu-
domenopause and ﬁnally a remission of the disease. The patient
will be hypoestrogenic due to suppression of the ovarian steroido-
genesis [14]. A synthetic oral progestin having progestational and
antigonadotrophic effects, but no androgenic, glucocorticoid or
mineralocorticoid activity is dienogest. It is believed to induce
both an antiproliferative effect on endometriotic cells and a reduc-
tion of estrogen levels due to the inhibition of ovarian function.
A regimen with 2mg a day is considered as the optimal dose for
provision of efﬁcacy and safety in endometriosis studies. In fact
this dosage moderately suppresses estradiol levels, and has high
oral bioavailability and a half-life suitable for once-daily admin-
istration. Compared to GnRH analogs dienogest seems to cause
less hypoestrogenic side effects and little changes in bone mark-
ers and bone mineral density offering better advantages in safety
and tolerability [20]. However because of endometriosis is an hor-
mone dependent disease, when the medical treatment is stopped
there is a relapse of the disease and hormonal therapy alone is
associated with a recurrence rate exceeding 50% within 6 months
after treatment is stopped [20]. The surgical approach has been
suggested to be superior to hormonal therapy alone since it can
address most of the intrathoracic pathologic features. The associa-
tion of surgical treatment followed by approximately 6 months of
hormone therapy may achieve up to 45 month follow up without
recurrence and is presently the preferred approach for treatment
and prevention [4,21]. Surgical treatment should be timed dur-
ingmenstruation for optimal visualization of pleurodiaphragmatic
endometriosis aswedid in our case. For such a purpose videothora-
coscopy is averyuseful tool since it assessesboth thediaphragmatic
surfaceand thepleural cavityand is able todetect typicalblueberry-
like spots or purple–red foci, although it has been reported that
in 8.5% of explored cases no pathologic ﬁndings were demon-
strated. [1,3]. Suturing the defect, endoscopic resection of the area,
covering the diaphragmatic surface with polyglactin mesh are
among the commonly reported surgical procedures which, how-
ever, do not prevent the risk of CP to recur. Therefore, in patients
with endometriosis-related catamenial pneumothorax, pleurode-
sis plays amajor role, whenmicroscopic endometrial foci, or newly
implanted lesions cannot be detected [2,12]. In our casewe found a
single typical purple–red spot on the right posterior diaphragmatic
surface but no other deposits nor fenestrations were detected. This
is why we preferred to limit our surgical procedure to resection of
the lesion andmechanical pleurodesis, the only successful reported
procedure, and combine it with the hormonal treatment to achieve
the best outcome.
4. Conclusion
Catamenial pneumothorax is themost common presentation of
thoracic endometriosis syndrome and should always be suspected
in women with a suggestive history of recurrent pneumothorax
and pelvic/abdominal endometriosis [3,15]. Although the num-
ber of reported cases with catamenial pneumothorax is limited,
conservative treatment is insufﬁcient. Videothoracoscopy provides
magniﬁcation and better visualization of the pleural cavity and
diaphragm. Among surgical options videothoracoscopic resection
of detected lesions combinedwith pleurodesis is themost success-
ful one and, associated with hormonal therapy, reduces the risk of
recurrence.
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